Literature DB >> 14896166

Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan.

A S DOUGLAS, A BROWN.   

Abstract

Entities:  

Keywords:  COUMARIN/toxicity; PROTHROMBIN; VITAMIN K/therapeutic use

Mesh：

Substances：

Year:  1952        PMID： 14896166      PMCID： PMC2022702          DOI： 10.1136/bmj.1.4755.412

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Boeck's Sarcoid of Retina-Miliary Form.

Authors:  A E Macdonald
Journal:  Trans Am Ophthalmol Soc       Date:  1943

2.  The treatment of dicumarol-induced hypoprothrombinemia in dogs with emulsified vitamin K1 administered intravenously.

Authors:  M SHOSHKES; R P GEYER; G S YEE; F J STARE
Journal:  J Lab Clin Med       Date:  1950-10

3.  Antagonism of dicumarol by vitamin K preparations.

Authors:  R MILLER; W P HARVEY; C A FINCH
Journal:  N Engl J Med       Date:  1950-02-09       Impact factor: 91.245
  3 in total
  6 in total

1.  TO-DAY'S DRUGS. VITAMINS. (1).

Authors:  A G HOCKEN
Journal:  Br Med J       Date:  1964-01-18

2.  Anticoagulants and arteriosclerosis.

Authors:  K BALL
Journal:  Postgrad Med J       Date:  1955-03       Impact factor: 2.401

3.  The current status of the treatment of coronary heart disease.

Authors:  C K FRIEDBERG
Journal:  Can Med Assoc J       Date:  1953-02       Impact factor: 8.262

4.  Anticoagulants in coronary disease.

Authors:  A R GILCHRIST; J A TULLOCH
Journal:  Br Med J       Date:  1954-09-25

5.  Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.

Authors:  J N CHALMERS; M F DIXON; W POLACK
Journal:  Br Med J       Date:  1954-10-23

6.  Severe haemolytic reaction following the intravenous administration of emulsified vitamin K (mephyton).

Authors:  R E BEAMISH; V M STORRIE
Journal:  Can Med Assoc J       Date:  1956-01-15       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.